Transgenomic Sales Slip 6 Percent; Firm Sees Strong Finish for Year | GenomeWeb

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market Thursday that its revenues in the third quarter of 2009 fell 6 percent compared with the 2008 period, and that its net loss on the quarter was down 25 percent from the year-ago period.

The Omaha, Neb.-based genetic test provider said that it brought in revenues of $5 million for the three-month period ended Sept. 30, compared with $5.4 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.